Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 560-564

  Chui, De Hua ^a   Tanahashi, Hiroshi ^a   Ozawa, Kazuharu ^b   Ikeda, Sachiya ^b   Checler, Frédéric ^c   Ueda, Otoya ^b   Suzuki, Hiroshi ^b   Araki, Wataru ^a   Inoue, Haruhisa ^a   Shirotani, Keiro ^a   Takahashi, Keikichi ^a   Gallyas, Ferenc ^d   Tabira, Takeshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b Chugai Pharmaceutical   (Japan)

^c CNRS   (France)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PRESENILIN 1;

AGED; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SENILE PLAQUE; TRANSGENIC MOUSE;

EID: 0032895651     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8438     Document Type: Article

References (29)

1. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
2. Cruts, M., Van Broeckhoven, C. Presenilin mutations in Alzheimer's disease. Hum. Mutat. 11, 183-190 (1998).
3. Kamimura, K. et al. Familial Alzheimer's disease genes in Japanese. J. Neural. Sci. 160, 76-81 (1998).
4. Scheuner, D. et al. The amyloid β-protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870 (1996).
5. Lemere, C. A. et al. The E280A presenilin-1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nature Med. 2, 1146-1150 (1996).
6. Duff, K. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713 (1996).
7. Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996).
8. Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72 (1997).
9. Guo, Q. et al. Expression of mutant PS1 in PC12 cells increases their susceptibility to apoptosis by trophic factor withdrawal or by Aβ administration in vitro. J. Neurosci. 17, 4212-4222 (1997).
10. Wolozin, B. et al. Participation of presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 274, 1710-1713 (1996).
11. Gallyas, F. et al. Four modified silver methods for thick sections of formaldehyde-fixed perikarya of all neurons, microglia cells and capillaries. J. Neurosci. Methods 50, 159-164 (1993).
12. Gallyas, F. et al. Formation of "dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis). Acta Neuropathol. 83, 504-509 (1992).
13. Hardy, J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159 (1997).
14. Neve, R. L., Robakis, N. K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21, 15-19 (1998).
15. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527 (1995).
16. Irizarry, M. C. et al. APPSw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965-973 (1997).
17. Borchelt, D. R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin1 and amyloid precursor protein. Neuron 19, 939-945 (1997).
18. Holcomb, L. et al. Accelerated Alzheimer-type phenotype in trasgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgene. Nature Med. 4, 97-100 (1998).
19. Staufenbiel M. et al. Neuron loss in APP transgenic mice. Nature 395, 755-756 (1998).
20. Haass C. et al. Proteolytic processing of Alzheimer's disease associated proteins. J. Neural Transm. Suppl. 53:159-167 (1998).
21. Zhang, Z. et al. Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702 (1998).
22. Geula, C. et al. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med. 4, 827-831 (1998).
23. Crook, R. et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Med. 4, 452-459 (1998).
24. Mizoguchi, K. et al. Stress induces neuronal death in the hippocampus of castrated rats. Neurosci. Lett. 138, 157-160 (1992).
25. Chui, D.H. et al. Both N-terminal and C-terminal fragments of presenilin 1 colocalize with neurofibrillary tangles in neurons and dystrophic neurites of senile plaques in Alzheimer's disease. J. Neurosci. Res. 53, 99-106 (1998).
26. Liu, X.Z. et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406 (1997).
27. Chui, D.H. et al. Immunohistochemical analyses of the leprosy brain show low β-amyloid but high abnormal tau deposition. Am. J. Pathol. 145, 771-775 (1994).
28. Barelli H. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695-707 (1997).
29. Koike, F. et al. Immunohistochemical study of Alzheimer's disease using antibodies to synthetic amyloid and fibronectin. J. Neurol. Sci. 85, 9-15 (1988).